pyrrolidine dithiocarbamate has been researched along with Neuroretinitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwabuchi, K; Kitaichi, N; Kitamei, H; Kitamura, M; Namba, K; Ohno, S; Onoé, K; Yanagawa, Y; Yoshida, K | 1 |
1 other study(ies) available for pyrrolidine dithiocarbamate and Neuroretinitis
| Article | Year |
|---|---|
Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate.
Topics: Amino Acid Sequence; Animals; Antigen-Presenting Cells; Autoantigens; Cell Division; Crosses, Genetic; Drug Evaluation, Preclinical; Eye Proteins; Female; Gene Expression Regulation; Interleukin-1; Interleukins; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Molecular Sequence Data; Nervous System Autoimmune Disease, Experimental; NF-kappa B; Peptide Fragments; Protein Transport; Pyrrolidines; Retinitis; Retinol-Binding Proteins; RNA, Messenger; T-Cell Antigen Receptor Specificity; T-Lymphocyte Subsets; Thiocarbamates; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Uveitis | 2006 |